How do you know that something to do with heart failure was due Q3 2022 - also, you do know that delivery date was either in the March quarter of FY22 or the September quarter of CY22, either way it is past tense - or that mitral regurgitation is in "Q2 2023"? Genuine question as I do seem to struggle unravelling some of their announcements and updates. I saw mention of those conditions in one of the announcements but nothing about the timing.
Just to be pedantic companies don't get a FDA "approval" with a 510(k) process, but rather a "clearance". Apparently there is a difference.
Ann: Echo IQ Announces Positive Results From US Clinical Study, page-13
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
-0.005(2.22%) |
Mkt cap ! $129.4M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 22.5¢ | 21.3¢ | $602.2K | 2.763M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 272493 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 35712 | 3 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| EIQ (ASX) Chart |